Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Primary Immune Deficiencies
Pharma
Kedrion wins FDA nod for immunodeficiency disorder treatment
Italian plasma specialist Kedrion has scored an FDA approval for Qivigy, a treatment for a adults with primary humoral immunodeficiency.
Kevin Dunleavy
Sep 29, 2025 11:39am
CSL Behring's first commercial pitches Hizentra for PI patients
May 21, 2025 4:10pm
FDA signs off on Takeda's HyQvia as maintenance therapy for CIDP
Jan 16, 2024 11:12am
FDA blesses Takeda's HyQvia to treat children with PI
Apr 12, 2023 10:10am
